Intralesional corticosteroids are the mainstays of intralesional therapies and triamcinolone acetonide is the most widely used agent (10–40mg/mL) which is injected at 3–6weeks intervals. Adverse effects of treatment with corticosteroids including hypopigmentation, telangiectasia,dermal atrophy, delayed wound healing, and scar widening